Targeting chronic NFAT activation with calcineurin inhibitors in diffuse large B-cell lymphoma.
Bucher P, Erdmann T, Grondona P, Xu W, Schmitt A, Schürch C, Zapukhlyak M, Schönfeld C, Serfling E, Kramer D, Grau M, Klener P, Lengerke C, Schulze-Osthoff K, Lenz G, Hailfinger S.
Bucher P, et al. Among authors: schmitt a.
Blood. 2020 Jan 9;135(2):121-132. doi: 10.1182/blood.2019001866.
Blood. 2020.
PMID: 31794606
Free article.